Chemical investigation reveals new half-sandwich RuII complexes and their potential as caged compounds.
Six half‐sandwich Ru II coordination compounds of the general formula [Ru([9]aneS 3 )(L–L)(L′)][PF 6 ] n { 2 – 7 ; [9]aneS 3 = 1,4,7‐trithiacyclononane, L–L = 2,2′‐bipyridine (bpy), 1,2‐diaminoethane (en), (±)‐ trans ‐1,2‐diaminocyclohexane (dach), picolinate (pic); L′ = pyridine (py), 3‐acetylpyridine (3‐acpy), imidazole (im); n = 1 or 2, depending on the nature of L–L} were prepared and characterized. If irradiated with blue light ( λ = 400–490 nm) in aqueous solution, they readily dissociate the monodentate L′ ligand to generate selectively the corresponding aqua species. The extent and rate of photoinduced ligand release depend primarily on the nature of the chelating ligand (bpy >> en ≈ dach > pic) and, to a minor extent, on that of the leaving ligand (py > im > 3‐acpy). Photolabile compounds 2 – 5 showed no significant antiproliferative activity against the MDA‐MB‐231 human mammary carcinoma cell line, both in the dark and upon irradiation with blue light. The clean photodissociation process that characterizes this class of half‐sandwich Ru II compounds, and the substantial lack of toxicity of the photogenerated Ru aqua species, suggest that they might be suitable for the preparation of “caged” Ru II compounds. In the frame of this work, two unexpected dinuclear compounds, namely, [{Ru([9]aneS 3 )(en)} 2 (μ‐en)][CF 3 SO 3 ] 4 ( 9 ) and [{Ru([9]aneS 3 )} 2 (μ‐dach)(μ‐CH 3 O) 2 ][CF 3 SO 3 ] 2 · 2CH 3 OH ( 10 )―both containing rare examples of bridging en and dach ligands―were also isolated and structurally characterized.
No takes yet. Share an insight, caveat, or question.
Finazzi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: